EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tricuspid Regurgitation: Pathophysiology, Risk Stratification, and Implications for Intervention

Mariagrazia Piscione iD, Barbara Pala iD, Dario Gaudio, Paola Gualtieri iD, Mario Laudazi iD, Simone Steffani iD, Marcello Chiocchi iD, Ferdinando Iellamo iD, Francesco Giuseppe Garaci, Marco Alfonso Perrone iD, Laura Di Renzo iD

Journal of Clinical Medicine · 08.05.2026 · 15 (10) · 3622

DOI: 10.3390/jcm15103622 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.05.2026. Verfasst von Mariagrazia Piscione und 10 weiteren Autor:innen. Beteiligte Einrichtung: Asl 2 Abruzzo, Santissima Annunziata Hospital, 66100 Chieti, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Right heart failure (HF) and tricuspid regurgitation (TR) are closely interrelated conditions, linked by a bidirectional and self-perpetuating pathophysiological relationship. Alterations in right-ventricular (RV) loading conditions, pulmonary vascular impedance, and ventriculo-arterial (VA) coupling play a central role in the development and progression of TR, which in turn exacerbates RV volume overload and end-organ dysfunction.

Methods

This review provides a comprehensive overview of the pathophysiology of right HF and TR, focusing on the mechanisms underlying RV dysfunction, pressure–volume (PV) relationships, and pulmonary vascular load. We further examine the clinical implications of this interaction and summarize current strategies for risk stratification, with particular emphasis on disease-specific risk models.

Results

TR emerges both as a consequence and a driver of RHF. Conditions such as pulmonary hypertension (PH) and left-sided heart disease promote annular dilation and leaflet tethering, leading to functional TR. Conversely, TR increases RV volume overload, worsening chamber dilation, reducing effective forward stroke volume (SV), and accelerating disease progression. This vicious cycle results in progressive RV impairment, impaired left-ventricular filling through ventricular interdependence, and systemic venous congestion affecting renal and hepatic function. Traditional risk scores fail to capture this complex pathophysiology. In this context, TRISCORE integrates clinical, biological, and echocardiographic (TTE) parameters reflecting RV dysfunction and systemic involvement, providing a more comprehensive assessment of disease severity and prognosis.

Conclusions

TR should be considered not only a marker but also a key determinant of right HF progression. A multiparametric approach integrating pathophysiology and disease-specific risk stratification is essential to identifying the optimal therapeutic window and guiding clinical decision making.

Schlagwörter

Stichwörter der Autor:innen

TRISCOREmultimodality imagingright heart failurerisk scoretricuspid regurgitation

Autor:innen und Institutionen

  • Asl 2 Abruzzo, Santissima Annunziata Hospital, 66100 Chieti, Italy.
  • Renzetti Hospital, 66034 Lanciano, Italy.
  • PhD School of Applied Medical-Surgical Sciences, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy.
  • UOC Cardiologia Ospedale IDI-IRCCS, 00167 Rome, Italy.
  • Fondazione Policlinico Campus Bio-Medico, University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  • Section of Food Science, Clinical Nutrition and Pharmaceutical Sciences, Department of Biomedicine and Prevention, Tor Vergata University of Rome, Via Montpellier 1, 00133 Rome, Italy.

ORCID-Profile: Mariagrazia Piscione, Barbara Pala, Paola Gualtieri, Mario Laudazi, Simone Steffani, Marcello Chiocchi, Ferdinando Iellamo, Marco Alfonso Perrone, Laura Di Renzo

Zitieren

APA

Piscione, M., Pala, B., Gaudio, D., Gualtieri, P., Laudazi, M., Steffani, S., Chiocchi, M., Iellamo, F., Garaci, F. G., Perrone, M. A., & Di Renzo, L. (2026). Tricuspid Regurgitation: Pathophysiology, Risk Stratification, and Implications for Intervention. Journal of Clinical Medicine, 15(10), 3622. https://doi.org/10.3390/jcm15103622

Vancouver

Piscione M, Pala B, Gaudio D, Gualtieri P, Laudazi M, Steffani S, et al. Tricuspid Regurgitation: Pathophysiology, Risk Stratification, and Implications for Intervention. Journal of Clinical Medicine. 2026;15(10):3622. doi:10.3390/jcm15103622

BibTeX
@article{Piscione2026,
  author = {Piscione, Mariagrazia and Pala, Barbara and Gaudio, Dario and Gualtieri, Paola and Laudazi, Mario and Steffani, Simone and Chiocchi, Marcello and Iellamo, Ferdinando and Garaci, Francesco Giuseppe and Perrone, Marco Alfonso and Di Renzo, Laura},
  title = {Tricuspid Regurgitation: Pathophysiology, Risk Stratification, and Implications for Intervention},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {3622},
  doi = {10.3390/jcm15103622}
}
Kostenlos starten →